Top 10 Evidence-Based Recommendations

Curcumin blocks NF-κB and COX-2 and downshifts pro-inflammatory cytokines. Pairing with piperine boosts absorption ~20× by inhibiting CYP3A4/UGTs and P-gp, making clinical doses actually bioavailable. ^{[1] [4] [5]}

Meta-analysis of RCTs shows curcumin lowers CRP/hs-CRP meaningfully; osteoarthritis trials find pain/function gains comparable to NSAIDs with fewer AEs; a head-to-head RCT found curcumin ~equal to diclofenac for knee OA over 4 weeks. ^{[1] [2] [3]}

EPA/DHA are substrates for specialized pro-resolving mediators that actively stop inflammation. DHA may reduce some cytokines more than EPA in head-to-head trials. ^{[6] [8]}

Recent dose-response meta-analysis across 40 RCTs: omega-3s lower CRP in cardiometabolic groups (non-linear effect); RA trials show reduced NSAID use and modest pain benefit. ^{[6] [7]}

Boswellic acids inhibit 5-lipoxygenase, curbing leukotriene-driven inflammation in joints and connective tissue.

Meta-analysis of RCTs (n=545) shows clinically meaningful pain and function improvements; an RCT also found reductions in hs-CRP with standardized extract. ^{[9] [10]}

Gingerols/shogaols dampen COX-2 and NF-κB activity and reduce TNF-α/IL-6 in trials. ^{[11] [12]}

Meta-analyses of RCTs show small-to-moderate reductions in hs-CRP, TNF-α, IL-6, especially in metabolic conditions. ^{[11] [12]}

Flavonol that modulates NF-κB and mast-cell signaling; may lower CRP and IL-6 in higher-risk groups. ^{[13] [14]}

Meta-analyses show reductions in CRP overall and in diseased cohorts; effects on IL-6/TNF-α vary by dose/sex/health status. ^{[13] [14]}

Gut-immune crosstalk: probiotics reduce endotoxin leakage and rebalance Treg/Th17, decreasing systemic cytokines.

Multiple meta-analyses show significant reductions in hs-CRP, IL-6, and TNF-α across adult RCTs. ^{[15] [16] [17]}

Activates SIRT1/AMPK, indirectly inhibiting NF-κB and reducing hepatic/adipose cytokine output.

Updated meta-analyses show reductions in CRP (and sometimes TNF-α), especially at ≥500 mg/day and longer durations. ^{[18] [19] [20]}

Potent singlet-oxygen quencher stabilizes membranes, indirectly reducing inflammatory signaling.

Carotenoid meta-analysis shows CRP and IL-6 reductions; astaxanthin RCT meta-analysis finds CRP drops at ≥12 mg/day and ≥12 weeks. ^{[21] [22] [3]}

Catechins enhance antioxidant defenses and may nudge IL-1β down; effects on CRP/IL-6/TNF-α are mixed overall. ^{[23] [24] [25]}

Large 2025 RCT meta-analysis finds improvements in oxidative stress markers and IL-1β but not CRP/IL-6/TNF-α; older diabetic cohorts showed CRP drops. ^{[23] [24]}

Phycocyanin exhibits COX-2 inhibition and antioxidant effects that can trim CRP in some groups.

2025 meta-analysis suggests CRP reduction (WMD ≈ −0.55 mg/L) but with high heterogeneity; more robust trials needed. ^[26]